232 related articles for article (PubMed ID: 17322228)
1. US campaign aims to end industry gifts, speaking fees, and travel for doctors.
Tanne JH
BMJ; 2007 Feb; 334(7590):385. PubMed ID: 17322228
[No Abstract] [Full Text] [Related]
2. Physician-industry relations--will fewer gifts make a difference?
Steinbrook R
N Engl J Med; 2009 Feb; 360(6):557-9. PubMed ID: 19196671
[No Abstract] [Full Text] [Related]
3. Doctors and drug companies.
Blumenthal D
N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823
[No Abstract] [Full Text] [Related]
4. The baby with the bathwater.
Buyske J
Arch Surg; 2010 Jun; 145(6):577. PubMed ID: 20575190
[No Abstract] [Full Text] [Related]
5. US to require public disclosure of drug and device industry's financial ties to doctors.
Epstein K
BMJ; 2012 Jan; 344():e515. PubMed ID: 22262802
[No Abstract] [Full Text] [Related]
6. Pens and other pharmaceutical industry gifts.
Brody H
Am J Bioeth; 2003; 3(3):58-60. PubMed ID: 14594497
[No Abstract] [Full Text] [Related]
7. Thanks, but no thanks.
Bell H
Minn Med; 2008 Apr; 91(4):26-30. PubMed ID: 18549004
[No Abstract] [Full Text] [Related]
8. [Is it pertinent to investigate the relations between physicians and the drug industry].
Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
[TBL] [Abstract][Full Text] [Related]
9. The death of common sense.
Trachtman H
Am J Bioeth; 2003; 3(3):W31-W32. PubMed ID: 14594484
[No Abstract] [Full Text] [Related]
10. Small gifts, conflicts of interest, and the zero-tolerance threshold in medicine.
Krimsky S
Am J Bioeth; 2003; 3(3):50-2. PubMed ID: 14594492
[No Abstract] [Full Text] [Related]
11. Industry gifts: dos and don'ts.
Stirewalt K
Minn Med; 2012 Jan; 95(1):32. PubMed ID: 22355909
[No Abstract] [Full Text] [Related]
12. Psychological aspects of gifts from drug companies.
Tarshis GA
JAMA; 2003 Nov; 290(18):2405; author reply 2406-7. PubMed ID: 14612469
[No Abstract] [Full Text] [Related]
13. The ethics of pharmaceutical industry relationships with medical students.
Rogers WA; Mansfield PR; Braunack-Mayer AJ; Jureidini JN
Med J Aust; 2004 Apr; 180(8):411-4. PubMed ID: 15089733
[TBL] [Abstract][Full Text] [Related]
14. A social science perspective on gifts to physicians from industry.
Dana J; Loewenstein G
JAMA; 2003 Jul; 290(2):252-5. PubMed ID: 12851281
[No Abstract] [Full Text] [Related]
15. Doctors and drug companies.
Lambert LA
N Engl J Med; 2005 Feb; 352(7):733-4; author reply 733-4. PubMed ID: 15716575
[No Abstract] [Full Text] [Related]
16. Drug representatives: giving you lunch or stealing your soul?
Higgins SP
Dermatol Online J; 2007 Oct; 13(4):5. PubMed ID: 18319002
[TBL] [Abstract][Full Text] [Related]
17. Let the Sun Shine In! An Adventure in Open Payments.
Barry MJ
Ann Intern Med; 2018 Jan; 168(2):151-152. PubMed ID: 29335735
[No Abstract] [Full Text] [Related]
18. Truly independent research?
Lenzer J
BMJ; 2008 Aug; 337():a1332. PubMed ID: 18719008
[No Abstract] [Full Text] [Related]
19. Physician attitudes toward industry: a view across the specialties.
Korenstein D; Keyhani S; Ross JS
Arch Surg; 2010 Jun; 145(6):570-7. PubMed ID: 20566978
[TBL] [Abstract][Full Text] [Related]
20. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
